Close

Rating History for Esperion Therapeutics (ESPR) by Credit Suisse

More Stocks Rated by Credit Suisse | Latest Ratings for ESPR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/7/2023 Judah Frommer Upgrade Neutral
(Underperform)		 7.00
(6.50)		 6.34
(1.99)		 -68.61% Details